Search

Search Constraints

You searched for: Author/Creator Raverot, Gerald

Search Results

1. Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients. Issue 4 (19th September 2022)

2. Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients. Issue 4 (19th September 2022)

5. Efficacy and safety of dopamine agonists in patients treated with antipsychotics and presenting a macroprolactinoma. Issue 2 (1st August 2020)

6. Efficacy and safety of dopamine agonists in patients treated with antipsychotics and presenting a macroprolactinoma. Issue 2 (August 2020)

7. Efficacy and safety of dopamine agonists in patients treated with antipsychotics and presenting a macroprolactinoma. Issue 2 (August 2020)

8. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Issue 1 (January 2018)

9. IGSF1 mutations are the most frequent genetic aetiology of thyrotropin deficiency. Issue 6 (3rd November 2022)

10. Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?—that is the question. Issue 4 (23rd March 2023)